Loading clinical trials...
Loading clinical trials...
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects With A Urea Cycle Disorder With Inadequate Control on Standard of Care
Conditions
Interventions
KB195
Locations
19
United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
University of South Florida/ USF HEALTH
Tampa, Florida, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Washington University School of Medicine
St Louis, Missouri, United States
Icahn School of Medicine at Mount Sinai-Clinical Research Unit
New York, New York, United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Start Date
September 17, 2019
Primary Completion Date
February 2, 2021
Completion Date
March 2, 2021
Last Updated
January 25, 2022
NCT06805695
NCT04602325
NCT06953505
NCT06664840
NCT01257737
NCT00947544
Lead Sponsor
Kaleido Biosciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions